ANTIGENERATOR Trademark

Trademark Overview

On Friday, June 26, 2026, a trademark application was filed for ANTIGENERATOR with the United States Patent and Trademark Office. The USPTO has given the ANTIGENERATOR trademark a serial number of 99908061. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, June 26, 2026. This trademark is owned by Syncromune, Inc.. The ANTIGENERATOR trademark is filed in the Medical Instrument Products category with the following description:

medical devices, namely cryogenerators to control an Oncolytic Infusion Device (OID) to induce the release of antigens at the site of cryolysis by application of the OID at a particular biological site, whether in vitro or in vivo
antigenerator

General Information

Serial Number99908061
Word MarkANTIGENERATOR
Filing DateFriday, June 26, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, June 26, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkANTI GENERATOR
Goods and Servicesmedical devices, namely cryogenerators to control an Oncolytic Infusion Device (OID) to induce the release of antigens at the site of cryolysis by application of the OID at a particular biological site, whether in vitro or in vivo

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, June 26, 2026
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSyncromune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Lauderdale, FL 33308
US

Trademark Events

Event DateEvent Description
Friday, June 26, 2026NEW APPLICATION ENTERED
Friday, June 26, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

antigenerator site application cryolysis particular biological vivo vitro whether antigens release